Anji Pharmaceuticals Competitors and Similar CompaniesClear all

Anji Pharmaceuticals's competitors and similar companies include ZIOPHARM Oncology, Aptamer Group, OXGENE and Aera Therapeutics.

	Anji Pharmaceuticals Anji Pharmaceuticals is a pharmaceutical company specializing in high-value targets validated by human genetics.	ZIOPHARM Oncology ZIOPHARM Oncology is an American biopharmaceutical company developing novel therapeutics for the treatment of cancer.	Aptamer Group Aptamer Group is a company focusing on the development of nucleic acid aptamers.	OXGENE OXGENE (also known as Oxford Genetics) is a synthetic biology company.	Aera Therapeutics Aera Therapeutics is a biopharmaceutical company that develops transformative genetic medicines for modalities and therapeutic areas.
Founding Date	Founding Date 2018	Founding Date 2005	Founding Date 2008	Founding Date 2011	Founding Date 2021
Type	Type Private	Type Public	Type Private	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech genetics pharma	Tags Healthcare biotech genetics pharma	Tags Healthcare biotech genetics pharma	Tags Healthcare biotech genetics pharma	Tags Healthcare biotech genetics pharma
Locations	Locations Cambridge, US HQ Shanghai, CN	Locations Boston, US HQ	Locations Heslington, GB HQ Wilmslow, GB	Locations Oxford, GB HQ	Locations Boston, US HQ
Employees	Employees 3	Employees 7352% increase	Employees 343% increase	Employees 264% increase	Employees 801% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $5k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) £1m (FY, 2018)	Revenue (est.) N/A
Net income	Net income N/A	Net income ($4.2m) (FY, 2025)	Net income N/A	Net income (£2.7m) (FY, 2018)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 125.1m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 193m